Application of Mouse Parthenogenetic Haploid Embryonic Stem Cells as a Substitute of Sperm
November 19th, 2020
5.5K views
This article aims to demonstrate the use of parthenogenetic haploid embryonic stem cells as a substitute for sperm for the construction of semi-cloned embryos.
Overview
This article demonstrates the use of parthenogenetic haploid embryonic stem cells as a substitute for sperm in constructing semi-cloned embryos. The methodology allows for genetic manipulation of gametes, facilitating the study of genomic imprinting.
Key Study Components
Area of Science
- Embryonic stem cell research
- Genomic imprinting
- Reproductive biology
Background
- Haploid mouse embryonic stem cells can be modified to create embryos.
- Traditional gamete manipulation techniques are complex.
- Parthenogenetic stem cells offer a novel approach to embryo creation.
- This research is significant for understanding genetic contributions in embryonic development.
Purpose of Study
- To explore the potential of haploid embryonic stem cells as a sperm alternative.
- To investigate genomic imprinting through modified gametes.
- To demonstrate the procedure for creating semi-cloned embryos.
Methods Used
- Preparation of holding and microinjection pipettes.
- Intracytoplasmic injection of parthenogenic ES cells into oocytes.
- Flow cytometry for DNA content analysis.
- Culture of semi-cloned embryos to the blastocyst stage.
Main Results
- Successful injection of haploid ES cells into oocytes.
- Observation of polar bodies and embryo development.
- Generation of full-term female mice from semi-cloned embryos.
- Analysis of genetic modifications and their implications.
Conclusions
- Parthenogenetic haploid embryonic stem cells can effectively replace sperm.
- This method enhances the understanding of genomic imprinting.
- Potential applications in reproductive biology and genetic research.
Frequently Asked Questions
What are parthenogenetic haploid embryonic stem cells?
They are stem cells derived from an unfertilized egg that can develop into embryos.
How does this method contribute to genomic imprinting studies?
It allows for the manipulation of genetic material in embryos to observe imprinting effects.
What are the implications of creating semi-cloned embryos?
It opens new avenues for research in developmental biology and reproductive technologies.
Can this technique be applied to other species?
While this study focuses on mice, the principles may be adaptable to other species.
What challenges exist in this research?
Challenges include ensuring the viability of embryos and understanding genetic outcomes.
What is the significance of using flow cytometry in this study?
Flow cytometry allows for precise analysis of cell populations and genetic content.
Executive Industry Relevance
This protocol enables targeted manipulation of paternal genomic contributions in mouse embryos, offering a scalable system for de-risking hypotheses related to imprinting and germline transmission. By substituting sperm with genetically engineered haploid embryonic stem cells, researchers can isolate paternal allele effects without confounding maternal contributions, improving predictive confidence in target validation. The approach supports early discovery workflows where mechanistic clarity and allelic specificity are critical for portfolio triage.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of paternal allele function in embryonic development by replacing sperm with edited haploid embryonic stem cells.
- Operational Value: Provides a renewable source of genetically manipulable male gametic equivalents for consistent experimental input.
- Scientific Value: Facilitates study of genomic imprinting mechanisms through controlled disruption of differentially methylated regions such as H19.
Screening & Assay Development
- Scientific Value: Generates semi-cloned embryos with defined paternal genotypes for phenotypic screening of developmental outcomes.
- Operational Value: Standardizes embryo production via intracytoplasmic injection, reducing variability in gamete quality and enabling reproducible assay conditions.
- Scientific Value: Supports flow cytometry-based quantification of haploid/diploid cell populations to confirm genetic integrity prior to use.
Translational & Preclinical Research
- Scientific Value: Enables generation of fertile semi-cloned mice, allowing longitudinal assessment of genetic modifications through germline transmission.
- Operational Value: Supports preclinical modeling of imprinting disorders by producing embryos with defined epigenetic states.
- Scientific Value: Permits investigation of parent-of-origin effects in disease-relevant systems using androgenic or parthenogenetic haploid ESC lines.
Pipeline & Workflow Integration
The method fits within the discovery-to-preclinical continuum by enabling precise paternal genome editing before embryo formation, supporting hypothesis testing and mechanistic de-risking in early target validation.
- Discovery Biology: Allows isolation of paternal contribution to zygotic genome activation and imprinting establishment by controlling haESC genotype.
- Screening: Delivers standardized embryos with defined paternal genotypes for consistent phenotypic readouts across compound or genetic screens.
- Analytics: Enables DNA content analysis via flow cytometry to confirm haploid state and genetic modification efficiency before injection.
- Translational Research: Supports generation of semi-cloned offspring to assess long-term phenotypic and epigenetic consequences of paternal genome edits.
- Enterprise Reuse: Establishes a platform for iterative genetic modification of male gametic input, applicable across multiple targets and studies.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity in paternal gene function by eliminating maternal genomic noise in early embryos.
- Operational Value: Increases reproducibility through standardized haESC preparation and intracytoplasmic injection workflows.
- Strategic Value: Improves capital efficiency by enabling germline transmission studies without maintaining male breeding colonies.
- Portfolio Impact: Informs go/no-go decisions by revealing parent-of-origin-specific phenotypes early in discovery.
Implementation Considerations
- Expertise in mouse embryology, micromanipulation, and haploid embryonic stem cell culture is required.
- Microforge and piezo actuator systems are necessary for pipette preparation and precise intracellular delivery.
- Standardization of haESC line quality, including ploidy and genetic modification status, is critical for consistent outcomes.
- Adaptation to androgenic haESC lines enables paternal or maternal gamete substitution depending on study design.
- Embryo activation and culture conditions must be optimized to support development to blastocyst and term stages.
Biopharma FAQs
Why is membrane rupture of haploid embryonic stem cells required before injection?
Rupturing the plasma membrane prevents chromosome segregation defects during oocyte activation by ensuring chromosomal material is freely available in the ooplasm.
How does isolating the independent variable (paternal genome) improve target validation?
By replacing sperm with edited haploid embryonic stem cells, maternal genetic contributions are held constant, allowing clear attribution of phenotypes to paternal allele modifications.
What quantitative measurements confirm the suitability of haploid embryonic stem cells for sperm replacement?
Flow cytometry analysis verifies haploid state and detects genetic modifications, ensuring only properly modified cells are used for injection.
Why are replication requirements important for cross-functional collaboration in this method?
Standardized embryo production via intracytoplasmic injection allows multiple teams to generate comparable semi-cloned embryos for consistent phenotypic and molecular analysis.
What statistical analysis capabilities are needed before implementing this method in a discovery pipeline?
The ability to quantify haploid/diploid ratios and transgene expression rates via flow cytometry is essential to assess cell line quality and modification efficiency prior to use.
Chapters in this video
0:05
Introduction
1:09
Holding and Microinjection Pipette Preparation
2:58
Intracytoplasmic Double Knockout Parthenogenetic Haploid Embryonic Stem Cell (DKO-phaESC) Injection
5:34
Results: Representative Establishment and Application of DKO-phaESC
7:23
Conclusion
